- Published at
- by financialpost.com
positive
positive
BetterLife Announces Favorable Outcome in New York Legal Claims
VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife”) (CSE:
News for BetterLife Pharma Inc. (BETRF)
- Published at
- by gurufocus.com
positivepositiveBetterLife Obtains Favourable Cardiac Safety Data for BETR-001
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (”BetterLife” or the ”Company”) (CSE: BETR / BETRF / FRA: NPAU)- Published at
- by manilatimes.net
neutralneutralAhmad Doroudian Announces Filing of Early Warning Report Related to Ownership of Common Shares of Betterlife Pharma Inc.
VANCOUVER, British Columbia, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Ahmad Doroudian announces that he has filed an early warning report (the 'Report') announcing his direct and indirect ownership of 14,250,461 common shares (each, a 'Common Share') in the capital of BetterLife Pharma Inc. (the 'Company' or 'BetterLife”). Dr. Doroudian's ownership, representing approximately 11.01% of the Company's issued and outstanding Common Shares, is held as an investment based on his long-term views of the Company. Dr. Doroudian may increase or decrease his interest depending on market and other factors and may do so in the open market or through private transactions.- Published at
- by financialpost.com
positivepositiveBetterLife Announces Fully Subscribed Private Placement Financing
VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:- Published at
- by financialpost.com
positivepositiveBetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent
VANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:- Published at
- by investing.com
positivepositiveBetterLife Announces Closing of a Private Placement By Investing.com
BetterLife Announces Closing of a Private Placement- Published at
- by financialpost.com
positivepositiveBetterLife Announces Closing of a Private Placement
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:- Published at
- by financialpost.com
positivepositiveBetterLife Announces Closing of a Private Placement
VANCOUVER, British Columbia, June 14, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:- Published at
- by benzinga.com
positivepositiveBetterLife Announces Closing of a Private Placement - BetterLife Pharma (OTC:BETRF)
VANCOUVER, British Columbia, June 14, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (- Published at
- by financialpost.com
positivepositiveBetterLife Announces Intent to Complete Private Placement of Units
VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:- Published at
- by investorideas.com
mixedmixedBiotech Sector a Healthy Choice for Investors? (Nasdaq: ELTX) (Nasdaq: VRDN) (Nasdaq: KZIA) (Nasdaq: RGLS)
April 5, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to watch i...- Published at
- by benzinga.com
neutralneutralPsyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More - BetterLife Pharma (OTC:BETRF), Braxia Scientific (OTC:BRAXF)
Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research- Published at
- by benzinga.com
mixedmixedBetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue - BetterLife Pharma (OTC:BETRF), Braxia Scientific (OTC:BRAXF)
Psychedelics biotech BetterLife Pharma (OTCQB: BETRF) announced its non-hallucinogenic LSD derivative, BETR-001, is progressing through IND-enabling studies toward expected clinical studies targeting Major Depressive Disorder (MDD.)- Published at
- by prnewswire.com
neutralneutralThe Worldwide Cervical Dysplasia Industry is Expected to Reach $984.8 Million by 2027
/PRNewswire/ -- The "Cervical Dysplasia Market Research Report by Diagnostics Type, by Treatment Type, by End User, by Region - Global Forecast to 2027 -...- Published at
- by benzinga.com
mixedmixedProactive news headlines including BetterLife Pharma, HempFusion Wellness, Pure Gold Mining, Mirasol Resources and OTC Markets Group
New York, March 03, 2021 (GLOBE NEWSWIRE) -- - Medexus Pharmaceuticals Inc (CVE:MDP) shares climb as Canaccord Genuity upgrades rating to Buy from Hold ...PUR.LPHUNPGM.VP731.FNPAU.MUNPAU.FNPAU.BEMKVNFMEDXFMDP.VLRTNFL11A.SGL11A.MUL11A.FL11A.DUL11A.BEIPNFFIP.CNHLIXGMS1.FEXROFEXRO.VDMX.VDFPP.MUDFPP.FDFPP.BECBDHFBNCHFBNCH.VBETRFBETR.CNAUSAFAUSA.CNASND.TOASDRFALPPAGW.FAGNPFAGN.CN87CA.MU87CA.F2RJ.F2RJ.BE2P4.F2P4.BE2D9.SG2D9.F1O2.FOTCMMRZLFMRZ.VM8R.SGM8R.MUM8R.FM8R.BEKTRADMPWW3DM.F3DM.BETHBRFTBRD.V32GA.F- Published at
- by benzinga.com
neutralneutralBetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder
Vancouver, Feb. 02, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company ...